Cognyte Software (NASDAQ:CGNT) Releases FY 2025 Earnings Guidance

Cognyte Software (NASDAQ:CGNT - Get Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of -0.130--0.130 for the period, compared to the consensus estimate of -0.180. The company issued revenue guidance of $333.2 million-$346.8 million, compared to the consensus revenue estimate of $333.5 million. Cognyte Software also updated its FY25 guidance to ($0.13) EPS.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CGNT. Needham & Company LLC reissued a hold rating on shares of Cognyte Software in a research note on Tuesday. StockNews.com cut Cognyte Software from a strong-buy rating to a buy rating in a research report on Thursday, March 7th.

Get Our Latest Analysis on Cognyte Software

Cognyte Software Stock Performance

NASDAQ CGNT traded down $1.14 during trading hours on Tuesday, hitting $7.27. 2,531,155 shares of the company traded hands, compared to its average volume of 446,418. The business's 50-day moving average is $7.60 and its 200-day moving average is $6.08. Cognyte Software has a twelve month low of $3.31 and a twelve month high of $8.53. The stock has a market capitalization of $500.47 million, a price-to-earnings ratio of -12.27 and a beta of 1.68.


Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Quantbot Technologies LP bought a new stake in Cognyte Software in the first quarter valued at approximately $45,000. Lazard Asset Management LLC acquired a new stake in shares of Cognyte Software in the 2nd quarter valued at $56,000. M&T Bank Corp boosted its holdings in shares of Cognyte Software by 52.8% in the 1st quarter. M&T Bank Corp now owns 16,559 shares of the medical device company's stock valued at $56,000 after purchasing an additional 5,724 shares in the last quarter. State of Wyoming boosted its holdings in shares of Cognyte Software by 72.9% in the 2nd quarter. State of Wyoming now owns 9,794 shares of the medical device company's stock valued at $60,000 after purchasing an additional 4,130 shares in the last quarter. Finally, Alpine Global Management LLC acquired a new stake in shares of Cognyte Software in the 4th quarter valued at $62,000. 72.92% of the stock is owned by institutional investors and hedge funds.

About Cognyte Software

(Get Free Report)

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company also offers network intelligence analytics, open source and threat intelligence analytics, and operational intelligence analytics solutions.

Featured Articles

Should you invest $1,000 in Cognyte Software right now?

Before you consider Cognyte Software, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognyte Software wasn't on the list.

While Cognyte Software currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Featured Articles and Offers

Search Headlines: